MARK JENNINGS, MD
Internal Medicine Physician · ALLEN, TX
Individual Active NPI 1336379783
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,069 | 170,397 | $10,005,496 | $4,034,801 | $3,216,453 |
| 2023 | 1,168 | 198,569 | $11,142,314 | $4,241,103 | $3,375,299 |
| 2022 | 1,207 | 195,507 | $11,012,000 | $4,196,192 | $3,354,977 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 14,250 | $1 | $1 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13,927 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 12,780 | $31 | $25 |
| J9271 | Injection, pembrolizumab, 1 mg | 11,600 | $56 | $45 |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | 8,700 | $6 | $4 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 8,000 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 7,380 | $49 | $39 |
| J9267 | Injection, paclitaxel, 1 mg | 6,968 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 4,810 | $2 | $1 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 3,300 | $26 | $20 |
| J1453 | Injection, fosaprepitant, 1 mg | 3,300 | $0 | $0 |
| Q5126 | Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg | 3,260 | $58 | $46 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Internal Medicine Physician | 207R00000X | ✓ | P1880 | TX |
| Student in an Organized Health Care Education/Training Program | 390200000X | — | — |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Internal Medicine Physician providers in Texas
- NPI 1083922843
- NPI 1982870416
- NPI 1912223892
- NPI 1285488080
- NPI 1649406281
- NPI 1831350461
- NPI 1154685881
- NPI 1053977942
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.